FHL3 Protein (Myc-DYKDDDDK Tag)

Catalog No. ABIN2721143

Recombinant FHL3 protein expressed in HEK-293 Cells.

Quick Overview for FHL3 Protein (Myc-DYKDDDDK Tag) (ABIN2721143)

Target: FHL3 (Four and A Half LIM Domains 3 (FHL3))

Protein Type: Recombinant

Origin: Human

Source: HEK-293 Cells

Application: Antibody Production (AbP), Standard (STD)

Purity: > 80 % as determined by SDS-PAGE and Coomassie blue staining

Product Details

Purification tag / Conjugate: This FHL3 protein is labelled with Myc-DYKDDDDK Tag.

Characteristics:

• Recombinant human FHL3 protein expressed in HEK293 cells.
• Produced with end-sequenced ORF clone

Application Details

Application Notes: Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays

Comment:

The tag is located at the C-terminal.

Restrictions: For Research Use only

Handling

Concentration: 50 μg/mL

Buffer: 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.

Storage: -80 °C

Storage Comment: Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.

Target Details

Target: FHL3 (Four and A Half LIM Domains 3 (FHL3))

Alternative Name: Fhl3

Background: The protein encoded by this gene is a member of a family of proteins containing a four-and-a-half LIM domain, which is a highly conserved double zinc finger motif. The encoded protein has been shown to interact with the cancer developmental regulators SMAD2, SMAD3, and SMAD4, the skeletal muscle myogenesis protein MyoD, and the high-affinity IgE beta chain regulator MZF-1. This protein may be involved in tumor suppression, repression of MyoD expression, and repression of IgE receptor expression. Two transcript variants encoding different isoforms have been found for this gene.

Molecular Weight: 31 kDa

NCBI Accession: NP_004459